Indole derivatives.

MYPI1991001896A0Inactive Publication Date: 1992-04-15PFIZER INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1991001896
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1990-10-15
Filing Date
1991-10-15
Publication Date
1992-04-15
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

COMPOUNDS OF THE FORMULA WHEREIN N IS 0, 1 OR 2; R1 IS HYDROGEN; R2 IS SELECTED FROM HYDROGEN, HALOGEN, CYANO, OR4, -(CH2)M-(C=O)NR5R6, -(CH2)M-SO2NR5R6, -(CH2)M-NR7(C=O)R8, -(CH2)M-NR7SO2R8, -(CH2(M-S(O)XR8, -(CH2)M-NR7(C=O)NR5R6, -(CH2)M-NR7(C=O)OR9, AND -CH=CH(CH2)YR10; R3 IS SELECTED FROM HYDROGEN AND C1 TO C6 LINEAR OR BRANCHED ALKYL; R4 IS SELECTED FROM HYDROGEN, C1 TO C6 ALKYL, AND ARYL; R5 AND R6 ARE INDEPENDENTLY SELECTED FROM HYDROGEN, C1 TO C6 ALKYL, ARYL, AND C1 TO C3 ALKYL-ARYL OR R5 AND R6 TAKEN TOGETHER TO FORM A 4, 5, OR 6 MEMBERED RING; R7 AND R8 ARE INDEPENDENTLY SELECTED FROM HYDROGEN C1 TO C6 ALKYL, ARYL, AND C1 TO C3 ALKYL-ARYL; R9; R9 IS SELECTED FROM HYDROGEN, C1 TO C6 ALKYL, ARYL, AND C1 TO C3 ALKYL-ARYL; R10 IS SELECTED FROM -(C=O) NR5R6 AND -SO2NR5R6, WHEREIN R5 AND R6 ARE DEFINED AS ABOVE, AND -NR7(C=O)R8, -NR7SO2R8, -NR7(C=O)NR5R6, -S(O)XR8 AND -NR7(C=O)OR9, WHEREIN R7, R8, AND R9 ARE AS DEFINED ABOVE; Y IS 0, 1, 2, 3 OR 4; X IS 1 OR 2; M IS 0, 1, 2, OR 3; AND THE ABOVE ARYL GROUPS AND THE ARYL MOIETIES OR THE ABOVE ALKYLARYL GROUPS ARE INDEPENDENTLY SELECTED FROM PHENYL AND SUBSTITUTED PHENYL, WHEREIN SAID SUBSTITUTED PHENYL MAY BE SUBSTITUTED WITH ONE TO THREE GROUPS SELECTED FROM C1 TO C4 ALKYL, HALOGEN, HYDROXY, CYANO, CARBOXAMIDE, NITRO, AND C1 TO C4 ALKOXY AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ARE NEW. THESE COMPOUNDS ARE USEFUL PSYCHOTHERAPEUTICS AND ARE POTENT SEROTONIN (5-HT1) AGONISTS AND MAY BE USED IN THE TREATMENT OF DEPRESSION, ANXIETY, EATING DISORDERS, OBESITY DRUG ABUSE, CLUSTER HEADACHE, MIGRAINE, PAIN CHRONIC PAROXYSMAL HEMICRANIA AND HEADACHE ASSOCIATED WITH VASCULAR DISORDERS, AND OTHER DISORDERS ARISING FROM DEFICIENT SEROTONERGIC NEUTRANSMISSION. THE COMPOUNDS CAN ALSO BE USED AS CENTRALLY ACTING ANTIHYPERTENSIVED AND VASODILATORS.
Need to check novelty before this filing date? Find Prior Art